Kept on Wikipedia:Zavegepant
From EverybodyWiki Bios & Wiki
Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist approved by the FDA on March 10, 2023 for the treatment of acute migraine.[1] The drug is manufactured by Pfizer.
References
- ↑ Lipton, Richard B.; Croop, Robert; Stock, David A.; Madonia, Jennifer; Forshaw, Micaela; Lovegren, Meghan; Mosher, Linda; Coric, Vladimir; Goadsby, Peter J. (2023-03-01). "Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial". The Lancet Neurology. 22 (3): 209–217. doi:10.1016/S1474-4422(22)00517-8. ISSN 1474-4422. PMID 36804093 Check
|pmid=value (help).
This article "Zavegepant" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Zavegepant. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
|
This page exists already on Wikipedia. |
